 | • レポートコード：QYR9ST04961 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、骨髄線維症治療の世界市場について調査・分析し、骨髄線維症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（輸血、化学療法、アンドロゲン療法）、用途別（病院、診療所、骨髄移植センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の骨髄線維症治療市場動向 ・主要企業別マーケットシェア ・骨髄線維症治療の種類別市場規模2014-2019 （輸血、化学療法、アンドロゲン療法） ・骨髄線維症治療の用途別市場規模2014-2019 （病院、診療所、骨髄移植センター） ・骨髄線維症治療の北米市場：主要企業・種類別/用途別市場規模 ・骨髄線維症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・骨髄線維症治療の中国市場：主要企業・種類別/用途別市場規模 ・骨髄線維症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・骨髄線維症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・骨髄線維症治療のインド市場：主要企業・種類別/用途別市場規模 ・骨髄線維症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Incyte、Novartis、Celgene、Mylan Pharmaceuticals、Bristol-Myers Squibb、Eli Lilly、Taro Pharmaceuticals、AllCells、Lonza Group、ATCC） ・骨髄線維症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Myelofibrosis or osteomyelofibrosis is a myeloproliferative disorder which is characterized by proliferation of abnormal clone of hematopoietic stem cells. Myelofibrosis is a rare type of chronic leukemia which affects the blood forming function of the bone marrow tissue. The disorder is found to occur mainly in the people of age 50 or more and shows no symptoms at an early stage. The common symptoms associated with myelofibrosis include weakness, fatigue, anemia, splenomegaly (spleen enlargement) and gout. However, the disease progresses very slowly and 10% of the patients eventually develop acute myeloid leukemia. Treatment options for myelofibrosis are mainly to prevent the complications associated with low blood count and splenomegaly.On the basis of treatment type, the global myelofibrosis treatment market has been segmented into blood transfusion, chemotherapy, androgen therapy and stem cell or bone marrow transplantation. Chemotherapy segment is expected to contribute major share due to easy availability of chemotherapeutic agents. Ruxolitinib is the only chemotherapeutic agent approved by the USFDA specifically for the treatment of myelofibrosis, which will drive the global myelofibrosis treatment market over the forecast period.
Northe America is anticipated to lead the global myelofibrosis treatment market due to comparatively high prevalence of the disease in the region.
In 2018, the global Myelofibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Myelofibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myelofibrosis Treatment development in United States, Europe and China.
The key players covered in this study
Incyte
Novartis
Celgene
Mylan Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly
Taro Pharmaceuticals
AllCells
Lonza Group
ATCC
Market segment by Type, the product can be split into
Blood Transfusion
Chemotherapy
Androgen Therapy
Market segment by Application, split into
Hospitals
Clinics
Bone Marrow Transplant Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Myelofibrosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Myelofibrosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Myelofibrosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Myelofibrosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Blood Transfusion
1.4.3 Chemotherapy
1.4.4 Androgen Therapy
1.5 Market by Application
1.5.1 Global Myelofibrosis Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Bone Marrow Transplant Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Myelofibrosis Treatment Market Size
2.2 Myelofibrosis Treatment Growth Trends by Regions
2.2.1 Myelofibrosis Treatment Market Size by Regions (2014-2025)
2.2.2 Myelofibrosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Myelofibrosis Treatment Market Size by Manufacturers
3.1.1 Global Myelofibrosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Myelofibrosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Myelofibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Myelofibrosis Treatment Key Players Head office and Area Served
3.3 Key Players Myelofibrosis Treatment Product/Solution/Service
3.4 Date of Enter into Myelofibrosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Myelofibrosis Treatment Market Size by Type (2014-2019)
4.2 Global Myelofibrosis Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Myelofibrosis Treatment Market Size (2014-2019)
5.2 Myelofibrosis Treatment Key Players in United States
5.3 United States Myelofibrosis Treatment Market Size by Type
5.4 United States Myelofibrosis Treatment Market Size by Application
6 Europe
6.1 Europe Myelofibrosis Treatment Market Size (2014-2019)
6.2 Myelofibrosis Treatment Key Players in Europe
6.3 Europe Myelofibrosis Treatment Market Size by Type
6.4 Europe Myelofibrosis Treatment Market Size by Application
7 China
7.1 China Myelofibrosis Treatment Market Size (2014-2019)
7.2 Myelofibrosis Treatment Key Players in China
7.3 China Myelofibrosis Treatment Market Size by Type
7.4 China Myelofibrosis Treatment Market Size by Application
8 Japan
8.1 Japan Myelofibrosis Treatment Market Size (2014-2019)
8.2 Myelofibrosis Treatment Key Players in Japan
8.3 Japan Myelofibrosis Treatment Market Size by Type
8.4 Japan Myelofibrosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Myelofibrosis Treatment Market Size (2014-2019)
9.2 Myelofibrosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Myelofibrosis Treatment Market Size by Type
9.4 Southeast Asia Myelofibrosis Treatment Market Size by Application
10 India
10.1 India Myelofibrosis Treatment Market Size (2014-2019)
10.2 Myelofibrosis Treatment Key Players in India
10.3 India Myelofibrosis Treatment Market Size by Type
10.4 India Myelofibrosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Myelofibrosis Treatment Market Size (2014-2019)
11.2 Myelofibrosis Treatment Key Players in Central & South America
11.3 Central & South America Myelofibrosis Treatment Market Size by Type
11.4 Central & South America Myelofibrosis Treatment Market Size by Application
12 International Players Profiles
12.1 Incyte
12.1.1 Incyte Company Details
12.1.2 Company Description and Business Overview
12.1.3 Myelofibrosis Treatment Introduction
12.1.4 Incyte Revenue in Myelofibrosis Treatment Business (2014-2019)
12.1.5 Incyte Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Myelofibrosis Treatment Introduction
12.2.4 Novartis Revenue in Myelofibrosis Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Myelofibrosis Treatment Introduction
12.3.4 Celgene Revenue in Myelofibrosis Treatment Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Myelofibrosis Treatment Introduction
12.4.4 Mylan Pharmaceuticals Revenue in Myelofibrosis Treatment Business (2014-2019)
12.4.5 Mylan Pharmaceuticals Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Myelofibrosis Treatment Introduction
12.5.4 Bristol-Myers Squibb Revenue in Myelofibrosis Treatment Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Company Details
12.6.2 Company Description and Business Overview
12.6.3 Myelofibrosis Treatment Introduction
12.6.4 Eli Lilly Revenue in Myelofibrosis Treatment Business (2014-2019)
12.6.5 Eli Lilly Recent Development
12.7 Taro Pharmaceuticals
12.7.1 Taro Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Myelofibrosis Treatment Introduction
12.7.4 Taro Pharmaceuticals Revenue in Myelofibrosis Treatment Business (2014-2019)
12.7.5 Taro Pharmaceuticals Recent Development
12.8 AllCells
12.8.1 AllCells Company Details
12.8.2 Company Description and Business Overview
12.8.3 Myelofibrosis Treatment Introduction
12.8.4 AllCells Revenue in Myelofibrosis Treatment Business (2014-2019)
12.8.5 AllCells Recent Development
12.9 Lonza Group
12.9.1 Lonza Group Company Details
12.9.2 Company Description and Business Overview
12.9.3 Myelofibrosis Treatment Introduction
12.9.4 Lonza Group Revenue in Myelofibrosis Treatment Business (2014-2019)
12.9.5 Lonza Group Recent Development
12.10 ATCC
12.10.1 ATCC Company Details
12.10.2 Company Description and Business Overview
12.10.3 Myelofibrosis Treatment Introduction
12.10.4 ATCC Revenue in Myelofibrosis Treatment Business (2014-2019)
12.10.5 ATCC Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Myelofibrosis Treatment Key Market Segments
Table Key Players Myelofibrosis Treatment Covered
Table Global Myelofibrosis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Myelofibrosis Treatment Market Size Market Share by Type 2014-2025
Figure Blood Transfusion Figures
Table Key Players of Blood Transfusion
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Androgen Therapy Figures
Table Key Players of Androgen Therapy
Table Global Myelofibrosis Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Bone Marrow Transplant Centers Case Studies
Figure Myelofibrosis Treatment Report Years Considered
Table Global Myelofibrosis Treatment Market Size 2014-2025 (Million US$)
Figure Global Myelofibrosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Myelofibrosis Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Myelofibrosis Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Myelofibrosis Treatment Market Share by Regions 2014-2019
Figure Global Myelofibrosis Treatment Market Share by Regions 2014-2019
Figure Global Myelofibrosis Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Myelofibrosis Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Myelofibrosis Treatment Market Share by Manufacturers (2014-2019)
Figure Global Myelofibrosis Treatment Market Share by Manufacturers in 2018
Table Global Myelofibrosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Myelofibrosis Treatment Product/Solution/Service
Table Date of Enter into Myelofibrosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Myelofibrosis Treatment Market Size Share by Type (2014-2019)
Figure Global Myelofibrosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Myelofibrosis Treatment Market Size Share by Application (2014-2019)
Figure Global Myelofibrosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Myelofibrosis Treatment Revenue Market Share by Application in 2018
Figure United States Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table United States Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Myelofibrosis Treatment Market Share by Type (2014-2019)
Table United States Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure Europe Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table Europe Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Myelofibrosis Treatment Market Share by Type (2014-2019)
Table Europe Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure China Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table China Myelofibrosis Treatment Market Size by Type (2014-20189) (Million US$)
Table China Myelofibrosis Treatment Market Share by Type (2014-2019)
Table China Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table China Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure Japan Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table Japan Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Myelofibrosis Treatment Market Share by Type (2014-2019)
Table Japan Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table Southeast Asia Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Myelofibrosis Treatment Market Share by Type (2014-2019)
Table Southeast Asia Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure India Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table India Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table India Myelofibrosis Treatment Market Share by Type (2014-2019)
Table India Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table India Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure Central & South America Myelofibrosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Myelofibrosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Myelofibrosis Treatment Market Share (2018-2019)
Table Central & South America Myelofibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Myelofibrosis Treatment Market Share by Type (2014-2019)
Table Central & South America Myelofibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Myelofibrosis Treatment Market Share by Application (2014-2019)
Table Incyte Company Details
Table Incyte Revenue in Myelofibrosis Treatment Business (2014-2019) (Million US$)
Figure Incyte Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Incyte Recent Development
Table Novartis Company Details
Table Novartis Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Novartis Recent Development
Table Celgene Company Details
Table Celgene Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Celgene Recent Development
Table Mylan Pharmaceuticals Company Details
Table Mylan Pharmaceuticals Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Mylan Pharmaceuticals Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Mylan Pharmaceuticals Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Taro Pharmaceuticals Company Details
Table Taro Pharmaceuticals Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Taro Pharmaceuticals Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Taro Pharmaceuticals Recent Development
Table AllCells Company Details
Table AllCells Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure AllCells Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table AllCells Recent Development
Table Lonza Group Company Details
Table Lonza Group Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure Lonza Group Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table Lonza Group Recent Development
Table ATCC Company Details
Table ATCC Revenue in Myelofibrosis Treatment Business (2014-2019)(Million US$)
Figure ATCC Revenue Growth Rate in Myelofibrosis Treatment Business (2014-2019)
Table ATCC Recent Development
Table Global Myelofibrosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Myelofibrosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Myelofibrosis Treatment Market Size Share by Regions in 2025
Figure United States Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Myelofibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Myelofibrosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Myelofibrosis Treatment Market Size by Product (2019-2025)
Figure Global Myelofibrosis Treatment Market Size by Product in 2025
Table Global Myelofibrosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Myelofibrosis Treatment Market Size by Application (2019-2025)
Figure Global Myelofibrosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
慢性特発性骨髄線維症の世界市場：市場規模・現状・予測 Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…- 骨髄移植の世界市場：市場規模・現状・予測 Bone marrow transplantation, also referred as hematopoietic stem cell transplantation is the process of replacing diseased or damaged bone marrow or bone marrow stem cells with healthy tissue. Bone marrow is a soft vascular tissue present in the interior of long bones, which is primarily responsible…
- 骨髄移植の世界市場：市場規模・現状・予測 A bone marrow transplant is a treatment that replaces unhealthy marrow with a healthy one. It's also called a blood or marrow transplant (BMT).In 2018, the global Bone Marrow Transplantation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of …
- 鎌状赤血球貧血治療の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 体外血液治療の世界市場：市場規模・現状・予測 The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases. United States region dominated the extracorporeal blood treatment market owing to t…